Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Conditions: Dyskinesia; Cerebral Palsy Interventions: Drug: Placebo; Drug: Valbenazine Sponsor: Neurocrine Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2022 Category: Research Source Type: clinical trials
Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia
Conditions: Primary Ciliary Dyskinesia; Kartagener Syndrome Intervention: Sponsors: University of North Carolina, Chapel Hill; Washington University School of Medicine; Children's Hospital Colorado; Stanford University; Seattle Children's Hospital; The Hospital for Sick Children; McGill University; Children's Hospital Medical Center, Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials
